The main office of represented Corporate Investor is situated in the Quebec. The venture was found in North America in Canada.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.
The usual cause for the fund is to invest in rounds with 1 partaker.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Logistics, Sports. Among the most popular portfolio startups of the fund, we may highlight SCALE AI.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
H55 | $70M | 24 Jul 2024 | Wallis, Switzerland | ||
Neurenati Therapeutics | $1M | 18 Apr 2024 | Montréal, Quebec, Canada | ||
Deep Sky | $10M | 08 May 2023 | Montréal, Quebec, Canada | ||
Dispersa | $1M | 20 Apr 2023 | Laval, Quebec, Canada | ||
Kaloom | $21M | 08 Sep 2022 | Montreal, Quebec, Canada | ||
WALO | $1M | 28 Feb 2022 | Quebec, Quebec, Canada | ||
Zilia | $3M | 11 Aug 2021 | Quebec City, Quebec, Canada | ||
Element AI | $159M | 13 Sep 2019 | Montreal, Quebec, Canada |
– Zilia is a Quebec, Canada-based ocular health startup.
– Company raised $4m in seed funding.
– The round was led by Anges Québec, with participation from the Government of Quebec through its new program, Impulsion PME, administered by Investissement Québec as a government agent, and other backers.
– The new investment will be used to complete the regulatory approval process for the clinical launch of Zilia Ocular, its first product.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
H55 | $70M | 24 Jul 2024 | Wallis, Switzerland | ||
Neurenati Therapeutics | $1M | 18 Apr 2024 | Montréal, Quebec, Canada | ||
Deep Sky | $10M | 08 May 2023 | Montréal, Quebec, Canada | ||
Dispersa | $1M | 20 Apr 2023 | Laval, Quebec, Canada | ||
Kaloom | $21M | 08 Sep 2022 | Montreal, Quebec, Canada | ||
WALO | $1M | 28 Feb 2022 | Quebec, Quebec, Canada | ||
Zilia | $3M | 11 Aug 2021 | Quebec City, Quebec, Canada | ||
Element AI | $159M | 13 Sep 2019 | Montreal, Quebec, Canada |
